<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01779076</url>
  </required_header>
  <id_info>
    <org_study_id>Dnr 2012 / 539</org_study_id>
    <nct_id>NCT01779076</nct_id>
  </id_info>
  <brief_title>Oxygen Level and Safe Emergence From Anesthesia</brief_title>
  <official_title>Emergence From General Anesthesia With Laryngeal Mask Airway and Increased End-expiratory Pressure Using 30% Oxygen is as Safe as With 100% Oxygen But Reduces the Area of Post Operative Atelectasis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Västmanland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Västmanland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using a protective ventilation strategy during general anesthesia from pre-oxygenation to
      emergence and selecting patients without risk of a difficult airway or intubation, a lower
      fraction of inspiratory oxygen (FIO2) can be used during extubation. This might reduce the
      postoperative area of atelectasis without desaturations becoming more common.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">June 11, 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area of atelectasis</measure>
    <time_frame>30 minutes</time_frame>
    <description>The area of atelectasis is investigated by computed tomography of the lungs postoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peripheral oxygen saturation (SpO2)</measure>
    <time_frame>3 hours</time_frame>
    <description>SpO2 is continuously assessed postoperatively.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Focus of Study is Postoperative Pulmonary Atelectacis</condition>
  <arm_group>
    <arm_group_label>100% oxygen during extubation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm the intervention will consist of 100 % oxygen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30% oxygen during extubation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm the intervention will consist of 30 % oxygen.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>30% oxygen</intervention_name>
    <arm_group_label>30% oxygen during extubation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>100% oxygen</intervention_name>
    <arm_group_label>100% oxygen during extubation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No sign of difficult airway or intubation

          -  Day case surgery in total intravenous anesthesia with laryngeal mask airway without
             adding regional anesthesia of plexus brachialis or muscle relaxant.

          -  Body mass index less than 35.

          -  American Society of Anesthesiologists physical status (ASA) class I-III

        Exclusion Criteria:

          -  Body mass index 35 or higher

          -  Increased risk of aspiration

          -  Obstructive sleep apnea syndrome

          -  Procedures during surgery making a former easy airway a difficult airway

          -  Need for opioids after extubation

          -  Hypothermia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mats Enlund, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Landstinget i Värmland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Västmanlands sjukhus Köping</name>
      <address>
        <city>Köping</city>
        <state>Västmanland</state>
        <zip>731 81</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2013</study_first_submitted>
  <study_first_submitted_qc>January 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2013</study_first_posted>
  <last_update_submitted>January 14, 2018</last_update_submitted>
  <last_update_submitted_qc>January 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Västmanland</investigator_affiliation>
    <investigator_full_name>Lennart Edmark</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

